Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20221018056224N1Phase 3Completed
Phase 3, randomised, single-blind trial in None comparing Topical lidocaine gel first with Placebo first (2 arms). Primary endpoint: Pain. Started May 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20221018056224N1.